ResearcherKanazawa UniversityNo recent work listed
Ayako Kitano
Matched on OpenAlex author ID A5026699413. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2012: 2 papers · 2013: 1 paper
Papers 3
- Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy. Co-author DOI 10.1371/journal.pone.0055289↗
- Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. Co-author DOI 10.1007/s00535-011-0484-9↗
- Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer. Last author DOI 10.4103/1477-3163.100866↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshiharu Motoo · 3 shared papers, 2012–2013 · strength 0.10
- Paper Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer. DOI 10.4103/1477-3163.100866↗
- Paper Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy. DOI 10.1371/journal.pone.0055289↗
- Paper Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. DOI 10.1007/s00535-011-0484-9↗
- Toshinari Minamoto Md · 3 shared papers, 2012–2013 · strength 0.10
- Paper Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer. DOI 10.4103/1477-3163.100866↗
- Paper Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy. DOI 10.1371/journal.pone.0055289↗
- Paper Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. DOI 10.1007/s00535-011-0484-9↗
- Takeo Shimasaki · 3 shared papers, 2012–2013 · strength 0.10
- Paper Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer. DOI 10.4103/1477-3163.100866↗
- Paper Aberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy. DOI 10.1371/journal.pone.0055289↗
- Paper Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine. DOI 10.1007/s00535-011-0484-9↗
- Yoshimichi Sai · 1 shared paper, 2013 · strength 0.03
- Naohisa Tomosugi · 1 shared paper, 2012 · strength 0.03
- Takanobu Takata · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.